Sucralfate — Mucosal protectant (aluminum complex). Study the mechanism, listed uses and warnings from the US label on one sourced card.
Generic name
Sucralfate
Brands
Carafate
Class
Mucosal protectant (aluminum complex)
Mechanism
Acts locally and forms an ulcer-adherent complex with proteinaceous exudate. A sucralfate-albumin film limits hydrogen-ion diffusion in vitro; the full ulcer-healing mechanism remains incompletely defined.
Used for
Short-term treatment of active duodenal ulcer in adults, for up to 8 weeks; Maintenance therapy after acute duodenal-ulcer healing in adults
Hypersensitivity (contraindicated); Aluminum can accumulate and become toxic in chronic renal failure or dialysis; other aluminum-containing products increase exposure
Label date: 20260902 · For learning, not clinical decisions. US label and brand information; always consult the current source.
Source snapshot checked: 2026-10-21. The source document and selected fields were compared. The complete card has not had an independent clinical review.
Mechanism: Substituted benzimidazole that inhibits the H+/K+ ATPase (proton pump) of the gastric parietal cell, blocking the final step of acid secretion.
On both cards: Common side effects — Diarrhea; Nausea · Interactions — Warfarin
Only on the Omeprazole card: Used for — Short-term treatment of active duodenal or benign gastric ulcer in adults; H. pylori eradication with the specified antibiotics in adults with duodenal ulcer disease; Short-term symptomatic GERD or erosive esophagitis treatment, and maintenance of healed erosive esophagitis, in patients aged 2 years and older; Long-term treatment of pathological hypersecretory conditions in adults · Common side effects — Headache; Abdominal pain; Flatulence · Warnings — Acute tubulointerstitial nephritis; C. difficile-associated diarrhea; Bone fracture with long-term use · Interactions — Clopidogrel; Rilpivirine, atazanavir, nelfinavir
Mechanism: Covalently binds the H+/K+ ATPase of the gastric parietal cell, suppressing the final step of acid production, basal and stimulated.
On both cards: Common side effects — Diarrhea; Nausea · Interactions — Warfarin
Only on the Pantoprazole card: Used for — Short-term healing and symptom relief of GERD-associated erosive esophagitis in adults and children aged 5 years and older; Maintenance of healed erosive esophagitis and reduction of heartburn relapse in adults with GERD; Long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome, in adults · Common side effects — Headache; Abdominal pain · Warnings — C. difficile-associated diarrhea; Bone fracture with long-term use; Vitamin B12 deficiency · Interactions — Rilpivirine-containing antiretrovirals; Methotrexate
Mechanism: Selective 5-HT3 receptor antagonist; 5-HT3 receptors are on vagal nerve terminals and in the chemoreceptor trigger zone.
On both cards: Common side effects — Constipation; Diarrhea
Only on the Ondansetron card: Used for — Prevention of chemotherapy-associated nausea and vomiting in adults; pediatric use from age 4 years is established only for moderately emetogenic chemotherapy; Prevention of nausea and vomiting from the specified radiotherapy regimens in adults; Prevention of postoperative nausea and vomiting in adults · Common side effects — Headache; Malaise / fatigue · Warnings — Hypersensitivity incl. anaphylaxis; QT prolongation / torsade de pointes; Serotonin syndrome · Interactions — Apomorphine; Serotonergic drugs (SSRIs, SNRIs)
An item counts as shared only when both cards use the same wording. If a card does not list an item, that is not a statement that the effect never occurs.